Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

CETP genotype and concentrations of HDL and lipoprotein subclasses in African-American men.

Samedy LA, Ryan GJ, Superko RH, Momary KM.

Future Cardiol. 2019 May;15(3):187-195. doi: 10.2217/fca-2018-0058. Epub 2019 May 31.

PMID:
31148465
2.

Professional Stereotypes of Interprofessional Education Naive Pharmacy and Nursing Students.

Thurston MM, Chesson MM, Harris EC, Ryan GJ.

Am J Pharm Educ. 2017 Jun;81(5):84. doi: 10.5688/ajpe81584.

3.

Unexpected DNA binding properties with correlated downstream biological applications in mono vs. bis-1,8-naphthalimide Ru(II)-polypyridyl conjugates.

Ryan GJ, Poynton FE, Elmes RB, Erby M, Williams DC, Quinn SJ, Gunnlaugsson T.

Dalton Trans. 2015 Oct 7;44(37):16332-44. doi: 10.1039/c5dt00360a.

PMID:
26305507
4.

Improving acid-fast fluorescent staining for the detection of mycobacteria using a new nucleic acid staining approach.

Ryan GJ, Shapiro HM, Lenaerts AJ.

Tuberculosis (Edinb). 2014 Sep;94(5):511-8. doi: 10.1016/j.tube.2014.07.004. Epub 2014 Jul 28.

PMID:
25130623
5.

Isolation and purification of Mycobacterium tuberculosis from H37Rv infected guinea pig lungs.

Shi L, Ryan GJ, Bhamidi S, Troudt J, Amin A, Izzo A, Lenaerts AJ, McNeil MR, Belisle JT, Crick DC, Chatterjee D.

Tuberculosis (Edinb). 2014 Sep;94(5):525-30. doi: 10.1016/j.tube.2014.05.003. Epub 2014 Jun 30.

PMID:
25037320
6.

National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations.

Geller AI, Shehab N, Lovegrove MC, Kegler SR, Weidenbach KN, Ryan GJ, Budnitz DS.

JAMA Intern Med. 2014 May;174(5):678-86. doi: 10.1001/jamainternmed.2014.136.

7.

Medication reconciliation: comparing a customized medication history form to a standard medication form in a specialty clinic (CAMPII 2).

Ryan GJ, Caudle JM, Rhee MK, Hickman JM, Tsui CW, Barnes CS, Haomia J, Ziemer DC.

J Patient Saf. 2013 Sep;9(3):160-8. doi: 10.1097/PTS.0b013e31828bf5cb.

PMID:
23965839
8.

Clinical effects of once-weekly exenatide for the treatment of type 2 diabetes mellitus.

Ryan GJ, Moniri NH, Smiley DD.

Am J Health Syst Pharm. 2013 Jul 1;70(13):1123-31. doi: 10.2146/ajhp120168. Review.

PMID:
23784159
9.

Diabetes care practice patterns of recent pharmacy graduates.

Ryan GJ, Chesnut R, Johnson JF, Jia H, Dye JT, Odegard PS.

J Pharm Pract. 2012 Jun;25(3):381-92. doi: 10.1177/0897190012442221. Epub 2012 Apr 27.

PMID:
22544619
10.

Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis.

Driver ER, Ryan GJ, Hoff DR, Irwin SM, Basaraba RJ, Kramnik I, Lenaerts AJ.

Antimicrob Agents Chemother. 2012 Jun;56(6):3181-95. doi: 10.1128/AAC.00217-12. Epub 2012 Apr 2.

11.

The impact of diabetes concentration programs on pharmacy graduates' provision of diabetes care services.

Ryan GJ, Chesnut R, Odegard PS, Dye JT, Jia H, Johnson JF.

Am J Pharm Educ. 2011 Aug 10;75(6):112. doi: 10.5688/ajpe756112.

12.

Lipoarabinomannan localization and abundance during growth of Mycobacterium smegmatis.

Dhiman RK, Dinadayala P, Ryan GJ, Lenaerts AJ, Schenkel AR, Crick DC.

J Bacteriol. 2011 Oct;193(20):5802-9. doi: 10.1128/JB.05299-11. Epub 2011 Aug 12.

13.

Review of the therapeutic uses of liraglutide.

Ryan GJ, Foster KT, Jobe LJ.

Clin Ther. 2011 Jul;33(7):793-811. doi: 10.1016/j.clinthera.2011.06.004. Epub 2011 Jul 8. Review.

PMID:
21741090
14.

Age-related androgen deficiency and type 2 diabetes.

Ryan GJ, Jobe LJ.

J Pharm Pract. 2011 Jun;24(3):316-22. doi: 10.1177/0897190010397719. Epub 2011 Apr 14. Review.

PMID:
21676855
15.

Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes.

Ryan GJ, Hardy Y.

J Clin Pharm Ther. 2011 Jun;36(3):260-74. doi: 10.1111/j.1365-2710.2010.01180.x. Review.

PMID:
21545609
16.

Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment.

Hoff DR, Ryan GJ, Driver ER, Ssemakulu CC, De Groote MA, Basaraba RJ, Lenaerts AJ.

PLoS One. 2011 Mar 21;6(3):e17550. doi: 10.1371/journal.pone.0017550.

17.

Multiple M. tuberculosis phenotypes in mouse and guinea pig lung tissue revealed by a dual-staining approach.

Ryan GJ, Hoff DR, Driver ER, Voskuil MI, Gonzalez-Juarrero M, Basaraba RJ, Crick DC, Spencer JS, Lenaerts AJ.

PLoS One. 2010 Jun 14;5(6):e11108. doi: 10.1371/journal.pone.0011108.

18.

Overcoming insulin "resistance": assisting patients in transitioning to insulin therapy.

Ryan GJ.

Am J Health Syst Pharm. 2010 Mar 15;67(6):441-4. doi: 10.2146/ajhp090021. No abstract available.

PMID:
20208049
19.

The DosR regulon of M. tuberculosis and antibacterial tolerance.

Bartek IL, Rutherford R, Gruppo V, Morton RA, Morris RP, Klein MR, Visconti KC, Ryan GJ, Schoolnik GK, Lenaerts A, Voskuil MI.

Tuberculosis (Edinb). 2009 Jul;89(4):310-6. doi: 10.1016/j.tube.2009.06.001. Epub 2009 Jul 3.

20.

Metronidazole lacks antibacterial activity in guinea pigs infected with Mycobacterium tuberculosis.

Hoff DR, Caraway ML, Brooks EJ, Driver ER, Ryan GJ, Peloquin CA, Orme IM, Basaraba RJ, Lenaerts AJ.

Antimicrob Agents Chemother. 2008 Nov;52(11):4137-40. doi: 10.1128/AAC.00196-08. Epub 2008 Aug 11.

21.

Highly effective DNA photocleavage by novel "rigid" Ru(bpy)(3)-4-nitro- and -4-amino-1,8-naphthalimide conjugates.

Ryan GJ, Quinn S, Gunnlaugsson T.

Inorg Chem. 2008 Jan 21;47(2):401-3. Epub 2007 Dec 14.

PMID:
18078333
22.

Impact of a diabetes certificate program on PharmD students' knowledge and skills.

Ryan GJ, Foster KT, Unterwagner W, Jia H.

Am J Pharm Educ. 2007 Oct 15;71(5):84.

23.

New pharmacologic approaches to treating diabetic retinopathy.

Ryan GJ.

Am J Health Syst Pharm. 2007 Sep 1;64(17 Suppl 12):S15-21. Review.

PMID:
17720889
24.

The safety of metformin in heart failure.

Roberts F, Ryan GJ.

Ann Pharmacother. 2007 Apr;41(4):642-6. Epub 2007 Mar 20. Review.

PMID:
17374622
25.

Reduced-dose influenza vaccine.

Wyatt KN, Ryan GJ, Sheerin KA.

Ann Pharmacother. 2006 Sep;40(9):1635-9. Epub 2006 Jul 11. Review.

PMID:
16835314
26.

Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the mu-opioid receptor and I2-imidazoline binding sites.

Dardonville C, Fernandez-Fernandez C, Gibbons SL, Ryan GJ, Jagerovic N, Gabilondo AM, Meana JJ, Callado LF.

Bioorg Med Chem. 2006 Oct 1;14(19):6570-80. Epub 2006 Jun 23.

PMID:
16797997
27.

Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.

Ryan GJ, Jobe LJ, Martin R.

Clin Ther. 2005 Oct;27(10):1500-12. Review.

PMID:
16330288
28.

Aggrenox((R)) versus other pharmacotherapy in preventing recurrent stroke.

Redman AR, Ryan GJ.

Expert Opin Pharmacother. 2004 Jan;5(1):117-23. Review.

PMID:
14680441
29.

Chromium as adjunctive treatment for type 2 diabetes.

Ryan GJ, Wanko NS, Redman AR, Cook CB.

Ann Pharmacother. 2003 Jun;37(6):876-85. Review.

PMID:
12773078
30.

Comparing the relationships between different types of self-efficacy and physical activity in youth.

Ryan GJ, Dzewaltowski DA.

Health Educ Behav. 2002 Aug;29(4):491-504.

PMID:
12137241
31.

The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.

Erdman DM, Cook CB, Greenlund KJ, Giles WH, El-Kebbi I, Ryan GJ, Gallina DL, Ziemer DC, Dunbar VG, Phillips LS.

Diabetes Care. 2002 Jan;25(1):9-15.

PMID:
11772894
32.
33.

The pattern of dyslipidemia among urban African-Americans with type 2 diabetes.

Cook CB, Erdman DM, Ryan GJ, Greenlund KJ, Giles WH, Gallina DL, El-Kebbi IM, Ziemer DC, Ernst KL, Dunbar VG, Phillips LS.

Diabetes Care. 2000 Mar;23(3):319-24.

34.

The effectiveness of a point-of-decision prompt in deterring sedentary behavior.

Russell WD, Dzewaltowski DA, Ryan GJ.

Am J Health Promot. 1999 May-Jun;13(5):257-9, ii.

PMID:
10538638
35.

Supplemental Content

Support Center